bioAffinity Technologies, Inc. (BIAFW) Operating margin 2022–2025
bioAffinity Technologies, Inc. (BIAFW) operating margin by fiscal year — reported operating income divided by reported revenue.
-171.6%FY2025 · since FY2022: -83511.5% → -171.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -171.6% | -75.9 pp |
| FY2024 | -95.6% | +219.2 pp |
| FY2023 | -314.8% | +83196.7 pp |
| FY2022 | -83511.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating cash flowBIAFW Free cash flowBIAFW Capital expendituresBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →